The diagnostic reliability of outpatient neurological care to patients with Parkinson’s disease

The diagnostic reliability of outpatient neurological care to patients with Parkinson’s disease

<p><em>Goal: </em>discussion of the revealing aspects of Parkinson’s disease (PD) by ambulatory neurologists. <em>Techniques: </em>a longitudinal epidemiological survey on applications to a specialized clinic<strong>...

Full description

Bibliographic Details
Main Authors:	Voskresenskaya O.N., Razdorskaya V.V., Yudina G.K.
Format:	Article
Language:	Russian
Published:	Saratov State Medical University 2012-06-01
Series:	Саратовский научно-медицинский журнал
Subjects:	early diagnosis extrapyramidal syndrome neurodegenerative disease Parkinson’s disease
Online Access:	http://www.ssmj.ru/system/files/201202_513-517.pdf

Similar Items

Parkinson's disease in Russia: prevalence and incidence
by: Razdorskaya V.V., et al.
Published: (2016-09-01)

Parkinson's disease and related disorders /
by: Riederer, P. (Peter)
Published: (2006)

Diagnostics and treatment of vascular parkinsonism
by: V.V. Yudina, et al.
Published: (2010-03-01)

AMANTADINES: EXPERIENCE OF APPLICATION FOR PARKINSON DISEASE
by: A. A. PILIPOVICH, et al.
Published: (2016-12-01)

Descriptive epidemiological study on patients with movement disorders, with emphasis on Parkinson’s disease
by: Luiza Serafini Balestrassi, et al.
Published: (2021-01-01)

COVID-19 and Parkinsonism: A Critical Appraisal
by: Francesco Cavallieri, et al.
Published: (2022-07-01)

EVALUATION OF THE INFLUENCE OF MOTOR DISORDERS ON THE QUALITY OF LIFE OF PATIENTS WITH COMOBIDITY OF PARKINSON'S DISEASE AND FRAILTY AND THE EFFICIENCY OF THEIR CORRECTION BY PHYSICAL THERAPY
by: I.V. Didoha
Published: (2021-02-01)

Flavonoids: Their putative neurologic roles, epigenetic changes, and gut microbiota alterations in Parkinson’s disease
by: Yasemin Açar, et al.
Published: (2023-12-01)

Levosulpiride-induced neurological adverse effects: A prospective study from a tertiary care center
by: Jacob Joe
Published: (2020-01-01)

Fluphenazine-Induced Neurotoxicity with Acute Almost Transient Parkinsonism and Permanent Memory Loss: Lessons from a Case Report
by: Roberto De Masi, et al.
Published: (2023-02-01)

Ninetieth Anniversary of Parkinson’s Disease «Substantia Nigra» Theory
by: O.N. Voskresenskaya, et al.
Published: (2009-06-01)

Akinetic rigid syndrome: An overview
by: Gupta Praveen, et al.
Published: (2007-01-01)

Recent Advances in the Roles of MicroRNA and MicroRNA-Based Diagnosis in Neurodegenerative Diseases
by: Juan Zhang, et al.
Published: (2022-11-01)

Paraoxonases at the Heart of Neurological Disorders
by: Fatimah K. Khalaf, et al.
Published: (2023-04-01)

Extrapyramidal symptoms as a consequence of organophosphate poisoning: Insights from a clinical case
by: J. Martins Correia, et al.
Published: (2021-04-01)

A Response to: "A Commentary on Antipsychotic-induced parkinsonism is associated with working memory deficits in schizophrenia-spectrum disorders.
by: Stephane ePotvin, et al.
Published: (2015-08-01)

Brain-Biomarker Changes in Body Fluids of Patients with Parkinson’s Disease
by: Cristina Cocco, et al.
Published: (2023-06-01)

Prevalence of Extrapyramidal Symptoms in In-Patients With Severe Mental Illnesses: Focus on Parkinsonism
by: Beatrice Roiter, et al.
Published: (2020-11-01)

Mitochondrial Dysfunction in Parkinson’s Disease—Cause or Consequence?
by: Chun Chen, et al.
Published: (2019-05-01)

Co-occurrence of multiple sclerosis and Parkinson disease
by: Vahid Shaygannejad, et al.
Published: (2016-01-01)

Molecular evolutionary and structural analysis of human UCHL1 gene demonstrates the relevant role of intragenic epistasis in Parkinson’s disease and other neurological disorders
by: Muhammad Saqib Nawaz, et al.
Published: (2020-10-01)

Pros and cons for statins use and risk of Parkinson's disease: An updated perspective
by: Hayder M. Al‐kuraishy, et al.
Published: (2023-04-01)

Naturalistic Study of Depression Associated with Parkinson’s Disease in a National Public Neurological Referral Center in Mexico
by: Reinhard Janssen-Aguilar, et al.
Published: (2022-02-01)

Parkinson's disease - a significant neurological challenge. Current knowledge of etiology, diagnosis and treatment
by: Lucjan Bednarz, et al.
Published: (2023-05-01)

Investigation of the oxidative status in patients with Parkinson's disease
by: Goncharova Z.A., et al.
Published: (2018-03-01)

Comparison of Serum Copper, Zinc, Lead, Aluminium and Iron Levels in Patients with Parkinson’s Disease with Healthy Controls in Tertiary Care Hospital
by: Tahir Asad, et al.
Published: (2022-11-01)

Early stages of Parkinson’s disease: aspects of the diagnosis and therapy
by: A. A. Pilipovich
Published: (2019-12-01)

OX40 Gene and Serum Protein Expression Profiles in Patients with Parkinson’s Disease
by: Azadeh Seyedjoodaki, et al.
Published: (2018-04-01)

No association between adult height and Parkinson's disease
by: Younggee Jeong, et al.
Published: (2023-01-01)

Cortistatin as a Novel Multimodal Therapy for the Treatment of Parkinson’s Disease
by: Ignacio Serrano-Martínez, et al.
Published: (2024-01-01)

Autophagy-Lysosomal Pathway as Potential Therapeutic Target in Parkinson’s Disease
by: Srinivasa Reddy Bonam, et al.
Published: (2021-12-01)

Insight Into the Role of Ferroptosis in Non-neoplastic Neurological Diseases
by: Jianwei Lei, et al.
Published: (2020-08-01)

Is aluminum exposure a risk factor for neurological disorders?
by: Elif Inan-Eroglu, et al.
Published: (2018-01-01)

Meaning in life and Parkinson’s disease in the UK Biobank
by: Angelina R. Sutin, et al.
Published: (2024-01-01)

Extrapyramidal syndromes of chronic kidney disease and dialysis (diabetic uremic syndrome) with reversible parkinsonism and lentiform fork sign: A case report and literature review including metformin-induced encephalopathy
by: Takeo Sakurai, et al.
Published: (2023-03-01)

Biomarkers in the early diagnosis of Parkinson's disease
by: Qian SUN, et al.
Published: (2013-08-01)

Deletion of the CYP2D6 gene as a likely explanation for the serious side effects of the antipsychotic drug pimozide: a case report
by: Fernando Facal, et al.
Published: (2023-08-01)

PGC-1s in the Spotlight with Parkinson’s Disease
by: Elena Piccinin, et al.
Published: (2021-03-01)

Alpha-Synuclein spreading in Parkinson disease
by: Ariadna eRecasens, et al.
Published: (2014-12-01)

Exploring therapeutic potential of mitophagy modulators using Drosophila models of Parkinson’s disease
by: Jyotsna Asthana, et al.
Published: (2022-10-01)